HeyJaredNatasha Persaud
- Indexed articles, last 90 days
- 17
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Cancer Therapy Advisor
- Top 5M sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Top Urology Influencer Dr Rena Malik Talks About Social Media and Sexual Health (opens the original)
Read excerpt
Dr Rena Malik is a board-certified urologist, pelvic surgeon, and sexual health expert whose social media channels educate millions of subscribers. Her latest book is The Hard Truth: Everything Men Need to Know for Good Health, Great Sex, and Long Life. I chose urology not because I actually knew what urology was. I remember being a medical student and falling in love with surgery, but wanting to look at the subspecialties. And then when I met the urologists, I was like, “Oh, these are my people
FDA Approves SpaceOAR Flex Hydrogel Rectal Spacer (opens the original)
Read excerpt
The US Food and Drug Administration (FDA) has granted 510(k) clearance for SpaceOAR™ Flex Hydrogel by Boston Scientific. It’s the latest iteration in rectal spacer technologies from the company. Radiation oncologists inject the gel using a transperineal approach to temporarily create a space cushion between the prostate and the rectum. The purpose is to reduce the radiation dose reaching the rectum during prostate cancer external beam radiation therapy (EBRT) and downstream bowel adverse effects
AUA Updates Guideline on Medical Management of Kidney Stones (opens the original)
Read excerpt
The American Urological Association (AUA) recently released updated guidelines on the medical management of kidney stones – its first update since 2014. Unlike the previous version, the 2026 AUA guideline’s 39 recommendations emphasize individualized and precision-based management over general advice. Importantly, children are discussed alongside adults. “This updated Guideline reflects important advances in our understanding of stone disease, including the role of tailored dietary strategies an
Real-World Experiences Support Belimumab, Telitacicept for Lupus Nephritis (opens the original)
Read excerpt
Real-world studies support belimumab and telitacicept for reducing disease activity in systemic lupus erythematosus (SLE), including lupus nephritis. In a Spanish retrospective, multicenter study, 202 patients with lupus nephritis were treated with belimumab between 2012 and 2024. Class 3 or 4 proliferative lupus nephritis affected 79.7% of patients and class 5 membranous disease 10.4%. Belimumab was started at renal involvement in 43.1% of patients, of whom approximately one-third received the
Finerenone Slows Kidney Function Decline, Cuts Cardiorenal Risk in Hypertensive Nephropathy (opens the original)
Read excerpt
In FIND-CKD trial participants with hypertensive nephropathy but without concomitant diabetes, adding finerenone to standard of care slowed kidney function decline and reduced the risk for major cardiorenal adverse events. Hiddo J.L. Heerspink, PhD, of the University of Groningen in the Netherlands, presented results from a prespecified subgroup analysis of the phase 3 trial during a late-breaking session at the European Society of Cardiology Congress. Full results were recently published in Eur
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Cancer Therapy Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.